Asia contributed close to 24,000 melanoma cases in 2020, with Australia and New Zealand having the highest incidence rates in the world.
Featured media on Novotech’s leadership and impact.
Expert insights and real-world perspectives.
In-depth perspectives on forces shaping clinical research.
Tracking science and trends across therapeutic areas.
Hear from experts shaping clinical development.
Conversations with leaders shaping drug development.
A global CRO and scientific partner advancing drug development.
Our impact extends beyond trials, shaping healthier futures worldwide.
A collaborative, science-driven approach.
Recognized for excellence across the industry.
Decades of clinical and scientific leadership.
A global clinical research leader with an award-winning culture.
A culture that empowers growth, innovation, and impact.
Explore career opportunities at Novotech.
Benefits and recognition that support your success.
Experts collaborating to advance clinical research.
A commitment to your growth and development.
Asia contributed close to 24,000 melanoma cases in 2020, with Australia and New Zealand having the highest incidence rates in the world.